Phase 1 study of DS-3201b to assess the effects of itraconazole and fluconazole on the pharmacokinetics of single oral administration of DS-3201b tablets in healthy Japanese subjects
Phase 1
- Conditions
- Healthy volunteers
- Registration Number
- JPRN-jRCT2080223846
- Lead Sponsor
- DAIICHI SANKYO CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 32
Inclusion Criteria
1.Japanese males
2.Age: >=20 and =<45 years (at the time of informed consent)
3.Body mass index (BMI) = Body weight (kg) / (Height [m])2: >=18.5 and <25.0 (at screening)
Exclusion Criteria
1.Having a history of hypersensitivity to drugs or other substances or being idiosyncratic (eg, having penicillin allergy)
2.Having alcohol or drug dependence
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method